Diltiazem in the Treatment of Calcinosis in Juvenile Dermatomyositis

Tulio Bertorini, Jeno I. Sebes, Genaro M.A. Palmieri, Masanori Igarashi, Linda H. Horner

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Subcutaneous calcifications occur in a variety of diseases, including juvenile dermatomyositis. These calcifications cause disabling symptoms that do not always respond to immunosuppressant therapy. The calcium antagonist diltiazem reduces subcutaneous calcifications in CREST syndrome and in isolated cases of children with dermatomyositis. Our study was performed to determine the effects of diltiazem when used as adjunctive therapy in children with dermatomyositis.

Original languageEnglish (US)
Pages (from-to)191-193
Number of pages3
JournalJournal of Clinical Neuromuscular Disease
Volume2
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Calcinosis
Dermatomyositis
Diltiazem
CREST Syndrome
Immunosuppressive Agents
Calcium
Therapeutics
Juvenile dermatomyositis

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Diltiazem in the Treatment of Calcinosis in Juvenile Dermatomyositis. / Bertorini, Tulio; Sebes, Jeno I.; Palmieri, Genaro M.A.; Igarashi, Masanori; Horner, Linda H.

In: Journal of Clinical Neuromuscular Disease, Vol. 2, No. 4, 01.01.2001, p. 191-193.

Research output: Contribution to journalArticle

Bertorini, Tulio ; Sebes, Jeno I. ; Palmieri, Genaro M.A. ; Igarashi, Masanori ; Horner, Linda H. / Diltiazem in the Treatment of Calcinosis in Juvenile Dermatomyositis. In: Journal of Clinical Neuromuscular Disease. 2001 ; Vol. 2, No. 4. pp. 191-193.
@article{1b7d8661ef5a4887a9f7f160ff37a3b3,
title = "Diltiazem in the Treatment of Calcinosis in Juvenile Dermatomyositis",
abstract = "Subcutaneous calcifications occur in a variety of diseases, including juvenile dermatomyositis. These calcifications cause disabling symptoms that do not always respond to immunosuppressant therapy. The calcium antagonist diltiazem reduces subcutaneous calcifications in CREST syndrome and in isolated cases of children with dermatomyositis. Our study was performed to determine the effects of diltiazem when used as adjunctive therapy in children with dermatomyositis.",
author = "Tulio Bertorini and Sebes, {Jeno I.} and Palmieri, {Genaro M.A.} and Masanori Igarashi and Horner, {Linda H.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1097/00131402-200106000-00005",
language = "English (US)",
volume = "2",
pages = "191--193",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Diltiazem in the Treatment of Calcinosis in Juvenile Dermatomyositis

AU - Bertorini, Tulio

AU - Sebes, Jeno I.

AU - Palmieri, Genaro M.A.

AU - Igarashi, Masanori

AU - Horner, Linda H.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Subcutaneous calcifications occur in a variety of diseases, including juvenile dermatomyositis. These calcifications cause disabling symptoms that do not always respond to immunosuppressant therapy. The calcium antagonist diltiazem reduces subcutaneous calcifications in CREST syndrome and in isolated cases of children with dermatomyositis. Our study was performed to determine the effects of diltiazem when used as adjunctive therapy in children with dermatomyositis.

AB - Subcutaneous calcifications occur in a variety of diseases, including juvenile dermatomyositis. These calcifications cause disabling symptoms that do not always respond to immunosuppressant therapy. The calcium antagonist diltiazem reduces subcutaneous calcifications in CREST syndrome and in isolated cases of children with dermatomyositis. Our study was performed to determine the effects of diltiazem when used as adjunctive therapy in children with dermatomyositis.

UR - http://www.scopus.com/inward/record.url?scp=0346995645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346995645&partnerID=8YFLogxK

U2 - 10.1097/00131402-200106000-00005

DO - 10.1097/00131402-200106000-00005

M3 - Article

VL - 2

SP - 191

EP - 193

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 4

ER -